Fracture prediction and calibration of a Canadian FRAX® tool: A population-based report from CaMos

L. A. Fraser, L. Langsetmo, C. Berger, G. Ioannidis, D. Goltzman, J. D. Adachi, A. Papaioannou, R. Josse, C. S. Kovacs, W. P. Olszynski, T. Towheed, D. A. Hanley, S. M. Kaiser, J. Prior, S. Jamal, N. Kreiger, J. P. Brown, H. Johansson, A. Oden, E. McCloskeyJ. A. Kanis, W. D. Leslie

Research output: Contribution to journalArticlepeer-review

154 Scopus citations

Abstract

Summary: A new Canadian WHO fracture risk assessment (FRAX®) tool to predict 10-year fracture probability was compared with observed 10-year fracture outcomes in a large Canadian population-based study (CaMos). The Canadian FRAX tool showed good calibration and discrimination for both hip and major osteoporotic fractures. Introduction: The purpose of this study was to validate a new Canadian WHO fracture risk assessment (FRAX®) tool in a prospective, population-based cohort, the Canadian Multicentre Osteoporosis Study (CaMos). Methods: A FRAX tool calibrated to the Canadian population was developed by the WHO Collaborating Centre for Metabolic Bone Diseases using national hip fracture and mortality data. Ten-year FRAX probabilities with and without bone mineral density (BMD) were derived for CaMos women (N=4,778) and men (N=1,919) and compared with observed fracture outcomes to 10 years (Kaplan-Meier method). Cox proportional hazard models were used to investigate the contribution of individual FRAX variables. Results: Mean overall 10-year FRAX probability with BMD for major osteoporotic fractures was not significantly different from the observed value in men [predicted 5.4% vs. observed 6.4% (95%CI 5.2-7.5%)] and only slightly lower in women [predicted 10.8% vs. observed 12.0% (95%CI 11.0-12.9%)]. FRAX was well calibrated for hip fracture assessment in women [predicted 2.7% vs. observed 2.7% (95%CI 2.2-3.2%)] but underestimated risk in men [predicted 1.3% vs. observed 2.4% (95%CI 1.7-3.1%)]. FRAX with BMD showed better fracture discrimination than FRAX without BMD or BMD alone. Age, body mass index, prior fragility fracture and femoral neck BMD were significant independent predictors of major osteoporotic fractures; sex, age, prior fragility fracture and femoral neck BMD were significant independent predictors of hip fractures. Conclusion: The Canadian FRAX tool provides predictions consistent with observed fracture rates in Canadian women and men, thereby providing a valuable tool for Canadian clinicians assessing patients at risk of fracture.

Original languageEnglish (US)
Pages (from-to)829-837
Number of pages9
JournalOsteoporosis International
Volume22
Issue number3
DOIs
StatePublished - Mar 2011

Bibliographical note

Funding Information:
We thank all those participants in CaMos whose careful responses and attendance made this analysis possible. Dr. Fraser is supported by the University of Western Ontario Resident Research Career Development Program. The Canadian Multicentre Osteoporosis Study was funded by the Canadian Institutes of Health Research (CIHR); Merck Frosst Canada Ltd.; Eli Lilly Canada Inc.; Novartis Pharmaceuticals Inc.; The Alliance: sanofi-aventis & Procter and Gamble Pharmaceuticals Canada Inc.; Servier Canada Inc.; Amgen Canada Inc.; The Dairy Farmers of Canada; and The Arthritis Society.

Keywords

  • Canada
  • FRAX
  • Fracture
  • Fracture prediction
  • Osteoporosis

Fingerprint

Dive into the research topics of 'Fracture prediction and calibration of a Canadian FRAX® tool: A population-based report from CaMos'. Together they form a unique fingerprint.

Cite this